Poster Quick Takes: Enhancing CAR T Cell Therapy for Solid Tumors
NCI Frederick researchers and colleagues are improving therapies that modify and equip a patient’s own immune cells to target their solid tumors. Their modification, while still at an early stage of development, can potentially minimize the risk that the armed cells will be therapeutically rejected.
06.16.2026